Theranica Announces Landmark Coverage Milestone as Nerivio® Exceeds Half of the U.S. Insured Population
Theranica Announces Landmark Coverage Milestone as Nerivio® Exceeds Half of the U.S. Insured Population (PR Newswire FDA.)
Theranica
Private
Theranica is a digital therapeutics company developing FDA-cleared neuromodulation devices for migraine and other neurological conditions. Nerivio, its wearable non-invasive vagus nerve stimulation device, became the first neuromodulation product to reach more than half of the U.S. insured population.
Company Info
Sector:Digital Therapeutics / Medical Devices
Headquarters:Netanya, Israel
Founded:2016
Website:www.theranica.com/
Recent News
Leadership Team
Careers & Job Openings